About Oakbio
Oakbio is a private company based in Sunnyvale, California. It has reported $26,566,198 raised in two offerings on Form D since February 2021. Its chief executive is David Tze.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 8, 2024 | Jul 24, 2024 | $17,284,998of $23.3M target | 14 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Feb 12, 2021 | Feb 25, 2021amended Jul 15, 2021 | $9,281,200fully sold | 36 | $257K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $26,566,198 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Oakbio's Form D filed Jul 24, 2024.
AK
Alex Kopelyan
Director
RH
Russell Howard
Director
MK
Mila Kyriacou
Director
DT
David Tze
Chief Executive Officer and director
MZ
Min Zhou
Director
Earlier filings also listed Kevin Tidwell (director, last listed Jul 2021) and Brian Sefton (executive officer and director, last listed Jul 2021).